Dr. Max is a leading pharmacy chain in Europe
Dr. Max Group is a Central and Eastern European business group operating in pharmaceutical sector. Headquartered in Prague, Czech Republic, the group currently stands as the 2nd largest pharmacy chain in Europe, while dominating in the CEE region. Guided by a promise to CARE and values it represents, Dr. Max strives to implement various improvements in the healthcare systems in the operating countries by providing accessibility, affordability, high-quality products and customer-centered approach in brick&mortar pharmacies, e-shop pharmacies and through managing wholesale distribution systems within countries of service.
We bring health to 17 European countries
As a leading pharmaceutical concern, we are steadily expanding by entering new retail and e-commerce pharmacy markets. We also operate as a wholesale distributor and outsourcing group, providing integrated services for existing pharmaceutical companies. United in expertise and mutual values, we serve in diverse markets with unique needs, adapting our approach to uphold the highest standards while maintaining a human touch. Our commitment to innovation and collaboration allows us to bring high-quality pharmaceutical solutions to millions across Europe.
Dr. Max BDC, s.r.o.
Na Florenci 2116/15
110 00 Prague 1
-
Czech Republic
4,000employees
488pharmacies
wholesale
marketing&salesfor strategic partners -
Slovakia
2,000employees
356pharmacies
marketing&salesfor strategic partners
-
Poland
4,000employees
543pharmacies
marketing&salesfor strategic partners
-
Italy
1300employees
210pharmacies
-
Romania
5,000employees
866pharmacies
wholesale
marketing&salesfor strategic partners
-
Serbia
1,700employees
320pharmacies
marketing&salesfor strategic partners
-
Hungary
20employees
marketing&salesfor strategic partners
-
Bulgaria
200employees
marketing&salesfor strategic partners
Dr. Max Group is a European pharmaceutical concern owned by Penta, an investment group established in 1994, operating primarily in the countries of Central and Eastern Europe. Their offices are located in Prague, Bratislava, Warsaw, and Limassol. The business areas of Penta Investments include long-term investing in healthcare, financial services, retail, manufacturing, media and real estate development. The companies of Penta’s portfolio employ more than 43,000 people, with more than 15,000 professionals working in healthcare. The group’s assets value reached €14 billion in 2022.